ResultsIQ

ResultsIQ › Latest results › Sudarshan Chemical Industries Limited

Sudarshan Chemical Industries Limited Q2 FY26 earnings call summary

NSE: SUDARSCHEM · BSE: 506655

Earnings call of 13 Nov 2025, summarised by AI from the filing.

Sudarshan Chemical Q2 FY26 sales flat YoY, EBITDA flattish; acquired group FY26 EBITDA guidance cut to €25-30 million on demand softness.

Key takeaways

  1. Guidance FY26 acquired group EBITDA guidance lowered to €25-30 million; Q3 subdued, recovery from Q4.
  2. Risk High customer inventories depleting slower than anticipated, impacting demand.

Original filing on BSE

Sudarshan Chemical Industries Limited Q1 FY27 results

As filed: Revenue ₹2,642 cr (+5% year on year), EBITDA ₹259 cr (+35% year on year), PAT ₹103 cr (+88% year on year), EBITDA margin 9.8% (+214 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹733 cr (+4% year on year), EBITDA ₹152 cr (+117% year on year), PAT ₹120 cr (+300% year on year), EBITDA margin 20.7% (+1,000 bps). Score 76 of 100, Above trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were well above it. EBITDA margin rose 1000 bps year on year. Tax rate 11%. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −14.5% in 30 days (Nifty 500: +0.9%).
  • Q3 FY26: Revenue ₹2,103 cr (+216% year on year), EBITDA ₹37.9 cr (−53% year on year), PAT −₹116 cr (−300% year on year), EBITDA margin 1.8% (−1,000 bps). Score 20 of 100, Below trend. Revenue growth was well above the company's own trend; EBITDA and profit before exceptional items growth were well below it. EBITDA margin fell 1000 bps year on year. Consolidated profit -11700% but standalone +41%. Revenue fell 12% from last quarter. Revenue rose ₹1,437 cr on a year ago, more than the ₹100 cr it added the year before. Share price after the results: −11.3% in 29 days (Nifty 500: −9.6%).
  • Q2 FY26: Revenue ₹2,387 cr (+243% year on year), EBITDA ₹132 cr (+39% year on year), PAT ₹19.0 cr (−37% year on year), EBITDA margin 5.5% (−812 bps). Score 39 of 100, Below trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 812 bps year on year. Other income 145% of PBT. Tax rate 55%. Consolidated profit -37% but standalone +21%. Revenue fell 5% from last quarter. Revenue rose ₹1,691 cr on a year ago, more than the ₹95.0 cr it added the year before. Share price after the results: −14.6% in 30 days (Nifty 500: +3.4%).
  • Q1 FY26: Revenue ₹2,507 cr (+295% year on year), EBITDA ₹192 cr (+140% year on year), PAT ₹55.0 cr (+90% year on year), EBITDA margin 7.7% (−496 bps). Score 62 of 100, In line with trend. Revenue and EBITDA growth were well above the company's own trend; profit growth was in line with it. EBITDA margin fell 496 bps year on year. Other income 35% of PBT. Tax rate 37%. Share price after the results: +12.7% in 29 days (Nifty 500: −1.3%).
  • Q4 FY25: Revenue ₹704 cr (+14% year on year), EBITDA ₹70.0 cr (−22% year on year), PAT ₹22.0 cr (−15% year on year), EBITDA margin 9.9% (−462 bps). Score 22 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA and profit before exceptional items growth were well below it. EBITDA margin fell 462 bps year on year. Other income 50% of PBT. Revenue rose ₹86.0 cr on a year ago, more than the ₹76.0 cr it added the year before. Share price after the results: +14.5% in 28 days (Nifty 500: +3.3%).
  • Q3 FY25: Revenue ₹666 cr (+18% year on year), EBITDA ₹80.0 cr (+29% year on year), PAT ₹1.0 cr (+64% year on year), EBITDA margin 12.0% (+106 bps). Score 40 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA and profit before exceptional items growth were below it. EBITDA margin rose 106 bps year on year. Other income 80% of PBT. Tax rate 80%. Revenue fell 4% from last quarter.
  • Q2 FY25: Revenue ₹696 cr (+16% year on year), EBITDA ₹95.0 cr (+46% year on year), PAT ₹30.0 cr (+108% year on year), EBITDA margin 13.7% (+283 bps). Score 82 of 100, Above trend. EBITDA margin rose 283 bps year on year. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Sudarshan Chemical Industries Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.